IXEKIZUMAB for Crohn's disease: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where IXEKIZUMAB was used for Crohn's disease.
Most Reported Side Effects for IXEKIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site pain | 3,799 | 11.3% | 0 | 64 |
| Psoriasis | 2,818 | 8.4% | 9 | 162 |
| Drug ineffective | 2,759 | 8.2% | 6 | 113 |
| Injection site erythema | 2,144 | 6.4% | 1 | 27 |
| Injection site reaction | 1,701 | 5.1% | 1 | 42 |
| Injection site swelling | 1,615 | 4.8% | 1 | 27 |
| Incorrect dose administered | 1,032 | 3.1% | 1 | 2 |
| Covid-19 | 861 | 2.6% | 16 | 67 |
| Product dose omission issue | 832 | 2.5% | 1 | 15 |
| Therapy interrupted | 796 | 2.4% | 0 | 46 |
| Injection site pruritus | 772 | 2.3% | 0 | 10 |
| Rash | 717 | 2.1% | 1 | 78 |
| Arthralgia | 714 | 2.1% | 1 | 83 |
| Diarrhoea | 667 | 2.0% | 3 | 67 |
| Pain | 656 | 2.0% | 1 | 77 |
Other Indications for IXEKIZUMAB
Psoriasis (16,569)
Product used for unknown indication (10,759)
Psoriatic arthropathy (5,798)
Ankylosing spondylitis (795)
Rheumatoid arthritis (298)
Axial spondyloarthritis (129)
Pustular psoriasis (81)
Guttate psoriasis (57)
Arthritis (47)
Polyarthritis (44)
Other Drugs Used for Crohn's disease
ADALIMUMAB (99,540)
INFLIXIMAB (40,796)
VEDOLIZUMAB (28,718)
USTEKINUMAB (22,537)
RISANKIZUMAB-RZAA (12,561)
INFLIXIMAB-DYYB (10,657)
HUMIRA (10,174)
CERTOLIZUMAB PEGOL (8,758)
UPADACITINIB (4,390)
MESALAMINE (2,930)